The Nanopass 32.5G pen needle is intended for use with a pen injector device for the subcutaneous injection of drugs including insulin and human growth hormone.
The Nanopass 32.5-range offers three different lengths - allowing to choose the suitable pen needle for each patient type.
Terumo has put its knowledge about reducing injection pain into the design of Nanopass 32.5G. Also users of long needles will benefit from it.
Nanopass 32.5G offers patients a more convenient insulin injection by applying dedicated Terumo technologies.
The unique asymmetric bevel1 of Nanopass cuts the skin instead of puncturing it. This decreases the resistance while penetrating the skin – designed to reduce pain.2
The special thin pen needle size of only 32.5G (0.22 mm) causes less skin trauma than larger needle sizes.3
The large inner diameter of Nanopass 32.5G optimizes the insulin flow for an easy insulin injection.
Colour Coding for easy identification of the preferred pen needle length.
32.5G(Ø 0.22 mm)
The brands listed are the property of the named companies.
1 Patented technology.2 Intra company data show less puncture resistance for the asymmetric edge compared to a standard 3-bevel. Lower puncture resistance is related to lower pain (T. Asakura, 2013, Jpn J Med Pharm Sci 69(1):147-155).3 The size of the perforation scar correlates with the outer diameter of the needle (T. Asakura, H. Seino, 2004, Jpn J Pharm. Health Care Sci., 30(6):368-376).
Our sales representatives are here for you
Didn't find your product?